‘Brainsway’ Receives New Product Innovation Award For Neuro-Psychiatry

Brainsway announced it has received the Frost & Sullivan 2012 Global New Product Innovation Award in neuro-psychiatric Devices for its Deep Transcranial Magnetic Stimulation (TMS) system. Frost & Sullivan is a Growth Partnership company that provides its clients researches, models and growth strategies. Brainsway, headquartered in Jerusalem, Israel, is developing noninvasive medical devices for the treatment of neurological and psychopathological disorders, such as addiction, schizophrenia, Alzheimer’s disease and post-traumatic stress disorder. Their initial focus is the treatment of major depression. View and share